Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Human beard hair medulla contains a unique and complex mix of keratins not found in other human tissues.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.